This page tracks new and upcoming treatment options for Ehlers-Danlos syndromes (EDS). What’s in development? What’s promising? What’s available soon? Current topics include ACLP, COL3A1, CRISPR, gene therapy, celiprolol, angiotensin II receptor blockers (ARBs), irbesartan, and more.

Subscribe